NARI vs. IMVT

In the year-to-date period, NARI achieves a -15.23% return, which is significantly higher than IMVT's -37.69% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Inari Medical, Inc. (NARI) and Immunovant, Inc. (IMVT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current NARI Sharpe Ratio is -0.31, which is higher than the IMVT Sharpe Ratio of -0.78. The chart below compares the historical Sharpe Ratios of NARI and IMVT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither NARI nor IMVT has paid dividends to shareholders.

The maximum NARI drawdown since its inception was -70.53%, smaller than the maximum IMVT drawdown of -93.59%. Use the drawdown chart below to compare losses from any high point for NARI and IMVT. For additional features, visit the drawdowns tool.

The current volatility for Inari Medical, Inc. (NARI) is 10.93%, while Immunovant, Inc. (IMVT) has a volatility of 13.50%. This indicates that NARI experiences smaller price fluctuations and is considered to be less risky than IMVT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Inari Medical, Inc. and Immunovant, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.